Cited by 236Pregnancy and preeclampsia studiesMicroRNA in disease regulationNeurological Complications and Syndromes

Elevated levels of hypoxia‐inducible microRNA‐210 in pre‐eclampsia: new insights into molecular mechanisms for the disease

Open access
Zhang, Yi, Fei, Mingyu, Xue, Geng, Zhou, Qi, Jia, Yin, Li, Li, Xin, Hong, Sun, Shuhan·2012·Journal of Cellular and Molecular Medicine

Abstract

Pre‐eclampsia is a leading cause of maternal and foetal morbidity and mortality worldwide. Insufficient uteroplacental oxygenation is believed to be responsible for the disease. However, what molecular events involve in hypoxic responses and how they affect placental development remain unclear. Recently, miRNAs have emerged as a new class of molecules in response to hypoxia. We show here that the expression of microRNA‐210 (mir‐210) is up‐regulated in patients with pre‐eclampsia, as well as in trophoblast cells cultured under hypoxic conditions. Ectopic expression of mir‐210 inhibited the migration and invasion capability of trophoblast cells. Ephrin‐A3 and Homeobox‐A9, which related with cell migration and vascular remodelling, were then experimentally validated as the functional targets of mir‐210 both in vivo and in vitro. Using luciferase reporter, chromatin immunoprecipitation (ChIP) and small interfering RNA (siRNA) experiments, we finally identified a new transcriptional mechanism that the overexpression of mir‐210 under hypoxia was regulated by NF‐κB transcriptional factor p50, apart from the well‐known HIF 1α. Taken together, our study implicates an important role for mir‐210 in the molecular mechanism of pre‐eclampsia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2011.01291.x

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other targets identified for miR-210 include the steroidogenic enzyme hydroxysteroid (17-ß) dehydrogenase 1, ephrin-A3 and homeobox-A9 which are involved in trophoblast cell migration and vascular remodeling, and thrombospondin type 1 domain containing 7A in the placental vasculature.

    “Besides mitochondria, other targets identified for miR-210 include the steroidogenic enzyme hydroxysteroid (17-ß) dehydrogenase 1 (272), ephrin-A3 and homeobox-A9 which are involved in trophoblast cell migration and vascular remodeling (611), and thrombospondin type 1 domain containing 7A in the placental vasculature (351).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [611]

  • MiR-210 is increased in normal placentas from pregnancies at high altitude, and in placentas from pregnancies complicated by pre-eclampsia.

    “It is increased in normal placentas from pregnancies at high altitude (121), and in placentas from pregnancies complicated by pre-eclampsia (272, 351, 401, 611).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [611]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, Y., Fei, M., Xue, G., Zhou, Q., Jia, Y., Li, L., Xin, H., & Sun, S.
Affiliations
  • Second Military Medical University (CN)
  • First Affiliated Hospital of Anhui Medical University (CN)
  • Second Hospital of Hebei Medical University (CN)
Corresponding author
Sun, Shuhan
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2012-01-27
Volume
16
Issue
2
Pages
249-259
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2037820964
Cited by
236
References
48
Citations by year
2026: 5 · 2025: 5 · 2024: 18 · 2023: 13 · 2022: 11 · 2021: 18 · 2020: 21 · 2019: 20 · 2018: 21 · 2017: 17 · 2016: 22 · 2015: 19 · 2014: 14 · 2013: 19 · 2012: 10
FWCI
18.95
Type
journal article
Language
en
Open access
Locations
  • Journal of Cellular and Molecular Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Psychiatry and Mental health › Neurological Complications and Syndromes
Keywords
preeclampsia, miR-210, hypoxia, trophoblast, ephrin-A3, cell migration, cell invasion, NF-κB p50, HIF-1α, placental development, vascular remodeling
MeSH terms
Hypoxia, Cell Movement, Female, Humans, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Trophoblasts, Case-Control Studies, Homeodomain Proteins, RNA Interference, RNA, Small Interfering, MicroRNAs, Ephrin-A3, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit, NF-kappa B p50 Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review